Development of scintillation proximity assays for prostaglandins and related compounds.
Baxendale
P M
PM
Amersham International plc, Cardiff Laboratories, Whitchurch, United Kingdom.
Martin
R C
RC
Hughes
K T
KT
Lee
D Y
DY
Waters
N M
NM
D015121:6-Ketoprostaglandin F1 alpha / Q000032:analysis; D015237:Dinoprost / Q000032:analysis; D015232:Dinoprostone / Q000032:analysis; D015777:Eicosanoids / Q000032:analysis*; D005069:Evaluation Studies as Topic; D005456:Fluorescent Dyes; D007975:Leukotriene B4 / Q000032:analysis; D008863:Microspheres; D015230:Prostaglandin D2 / Q000032:analysis; D011453:Prostaglandins / Q000032:analysis*; D011863:Radioimmunoassay / Q000295:instrumentation / Q000379:methods*; D013189:SRS-A / Q000032:analysis; D012588:Scintillation Counting / Q000379:methods*; D013048:Specimen Handling; D013929:Thromboxane B2 / Q000032:analysis
D015777:Eicosanoids; D005456:Fluorescent Dyes; D011453:Prostaglandins; D013189:SRS-A; D007975:Leukotriene B4; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; D015237:Dinoprost; D015232:Dinoprostone; D015230:Prostaglandin D2